7 Results for "

DEGS1

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "DEGS1" in MCE Product Catalog:

Cat. No.: HY-RS03682
Research Areas:  

Others

DEGS1 Human Pre-designed siRNA Set A contains three designed siRNAs for DEGS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS21551
Research Areas:  

Others

Degs1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Degs1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS28069
Research Areas:  

Others

Degs1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Degs1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
loading...
    loading...
Cat. No.: HY-153665
CAS No.: 2761446-55-1
Purity:  99.45%
Research Areas:  

Others

Deg-1 is a a bifunctional probe with a cleavage group and a covalent binding group. Deg-1 covalently binds to the target nucleic acid, and serves as click-degrader to cleave a nucleic acid molecule. Deg-1 has potential to selectively cleave target nucleic acids in cells [1]. It contains an azide group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing alkyne groups. It can also undergo ring strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing DBCO or BCN groups.
loading...
    loading...
Cat. No.: HY-P83490
Synonyms: MLD; DEGS; DES1; Des-1; FADS7; MIG15; DEGS-1

Host:  

Rabbit

Application:  

WB

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P83490A
Synonyms: MLD; DEGS; DES1; Des-1; FADS7; MIG15; DEGS-1

Host:  

Rabbit

Application:  

WB

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-183723
Research Areas:  

Metabolic Disease

GAA-4OH is a potent and irreversible dihydroceramide desaturase-1 (DES1) inhibitor with an IC50 of 0.6 μM and a Ki of 139.5 nM. GAA-4OH undergoes oxidation to form a reactive iminoquinone that covalently blocks DES1’s catalytic cavity, causing permanent enzyme inactivation. GAA-4OH modulates sphingolipid balance by reducing ceramide-to-dihydroceramide ratios in liver tissue. GAA-4OH improves liver steatosis, inflammation, fibrosis, and reduces pro-inflammatory and pro-fibrogenic gene expression. GAA-4OH can be used for the research of metabolic dysfunction-associated steatotic liver disease (MASLD) [1].
loading...
    loading...